News & Media
-
10/21/2023
ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
MD Anderson Cancer Center News Release
-
4/11/2022
AACR: Combination immunotherapy treatment effective before lung cancer surgery
MD Anderson Cancer Center News Release
-
2/18/2021
Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer -- Cascone T and Sepesi B.
MD Anderson Cancer Center News Release
-
11/20/2020
MD Anderson researchers present immunotherapy advances at Society for Immunotherapy of Cancer Annual Meeting. Highlights include positive clinical data from combination therapies in patients with melanoma and lung cancer - Cascone T and Sepesi B.
MD Anderson Newsroom
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.?